CN Patent

CN102869677A — 胃肠病症的治疗

Assigned to Ironwood Pharmaceuticals Inc · Expires 2013-01-09 · 13y expired

What this patent protects

本发明特征为肽、组合物及使用激活鸟苷酸环化酶C(GC-C)受体的肽和其它药剂用于治疗胃肠病症和病况的相关方法，所述胃肠病症和病况包括但不限于，肠易激综合征(IBS)、胃肠运动障碍、功能性胃肠病症、胃食管返流疾病(GERD)、十二指肠胃返流、克罗恩病、溃疡性结肠炎、炎性肠病、功能性胃灼热、消化不良、内脏痛、胃轻瘫、慢性假性肠梗阻(或假性结肠梗阻)、便秘相关的病症和病况和本文描述的其它病况和病症。

USPTO Abstract

本发明特征为肽、组合物及使用激活鸟苷酸环化酶C(GC-C)受体的肽和其它药剂用于治疗胃肠病症和病况的相关方法，所述胃肠病症和病况包括但不限于，肠易激综合征(IBS)、胃肠运动障碍、功能性胃肠病症、胃食管返流疾病(GERD)、十二指肠胃返流、克罗恩病、溃疡性结肠炎、炎性肠病、功能性胃灼热、消化不良、内脏痛、胃轻瘫、慢性假性肠梗阻(或假性结肠梗阻)、便秘相关的病症和病况和本文描述的其它病况和病症。

Drugs covered by this patent

Patent Metadata

Patent number
CN102869677A
Jurisdiction
CN
Classification
—
Expires
2013-01-09
Drug substance claim
No
Drug product claim
No
Assignee
Ironwood Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.